Therapy with murinized tobevibart and elebsiran is efficacious in a liver-chimeric mouse model of HDV infection.
- DOI
- 10.1016/j.jhepr.2025.101400
- Published
- 2025 Jun
- Container
- JHEP reports : innovation in hepatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jhepr.2025.101400,
title = {Therapy with murinized tobevibart and elebsiran is efficacious in a liver-chimeric mouse model of HDV infection.},
author = {Zhou J and Kaiser H and Rocha E and Terrell AN and Corti D and Purcell LA and Lempp FA and Puschnik AS},
year = {2025},
journal = {JHEP reports : innovation in hepatology},
doi = {10.1016/j.jhepr.2025.101400},
url = {https://doi.org/10.1016/j.jhepr.2025.101400}
}RIS
TY - JOUR TI - Therapy with murinized tobevibart and elebsiran is efficacious in a liver-chimeric mouse model of HDV infection. AU - Zhou J AU - Kaiser H AU - Rocha E AU - Terrell AN AU - Corti D AU - Purcell LA AU - Lempp FA AU - Puschnik AS PY - 2025 JO - JHEP reports : innovation in hepatology DO - 10.1016/j.jhepr.2025.101400 UR - https://doi.org/10.1016/j.jhepr.2025.101400 ER -
APA
J, Z., H, K., E, R., AN, T., D, C., LA, P., FA, L., & AS, P. (2025). Therapy with murinized tobevibart and elebsiran is efficacious in a liver-chimeric mouse model of HDV infection.. JHEP reports : innovation in hepatology. https://doi.org/10.1016/j.jhepr.2025.101400
Source records
- pubmed · retrieved 2026-09-27T16:47:50.972Z